Finding legitimacy for the role of budget impact in drug reimbursement decisions
OBJECTIVES: Research has shown that effectiveness, cost-effectiveness, and severity of illness each play a role in drug reimbursement decisions. However, the role of budget impact in such decisions is less obvious. Policy makers almost always demand a budget impact estimate yet seem reluctant to formally include budget impact as a rationing criterion. Health economists even reject budget impact as a legitimate criterion. For these reasons, it is important to examine its use in rationing decisions, and rationales underlying its use. METHODS: We trace several rationales supporting the use of bud... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2009 |
Schlagwörter: | *Budgets / *Decision Making / Cost-Benefit Analysis / Health Care Reform/*economics / Health Policy/*economics / Health Resources/economics / Humans / Insurance / Health / Reimbursement/*economics / Netherlands / Prescription Drugs/*economics / Resource Allocation/*economics |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29199037 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://repub.eur.nl/pub/19403 |